Skip to main content

Day: March 27, 2023

Nexalin Technology Provides 2022 Year-End Business Update

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided a business update for the year ended December 31, 2022. Mark White, CEO of Nexalin Technology stated, “Nexalin has made significant progress towards commencing clinical trials of our Gen-2 and Gen-3 neurostimulation devices in the United States. Nexalin’s enhanced neurostimulation devices combine innovation, frequencies and algorithms to provide an unprecedented solution for treating mental health disorders without the need for medication. Although our Gen-1 device was previously cleared by the U.S. Food and Drug Administration (FDA) to treat patients with anxiety, depression, and insomnia, we believe that the new devices will allow deeper penetration into the brain and provide enhanced patient response...

Continue reading

Tempo Automation Announces Definitive Agreement to Acquire Optimum Design Associates Extending Its Accelerated Manufacturing Platform to Electronic Design Services

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) — Tempo Automation Holdings, Inc. (NASDAQ: TMPO, “Tempo Automation” or “Tempo”), a leading software-accelerated electronics manufacturer, announced today that it has entered into a definitive agreement to acquire Optimum Design Associates, Inc. and Optimum Design Associates Pty. Ltd. (collectively “Optimum” or “Optimum Design Associates”), a fast-growing electronic design services company with offices in the United States and Australia that has delivered over 10,000 printed circuit board (PCB) designs to blue-chip customers. By vertically integrating electronic design and manufacturing, Tempo expects to be able to engage with customers even earlier in their product design process, streamlining the hardware development journey and providing a more efficient and faster way to get electronic...

Continue reading

Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Summary & Recent Highlights:Total revenue of $24.3 million, down $8.3 million, or 26%, year-over-year; up $2.7 million, or 13% quarter-over-quarter.U.S. revenue down 14% year-over-year; up 17% quarter-over-quarter. Cash system revenue represented approximately 71% of total systems and subscriptions revenue, compared to 60% in the prior year period.GAAP net loss attributable to stockholders of $9.9 million, compared to GAAP net loss attributable to stockholders of $4.3 million last year. Adjusted EBITDA loss of $6.3 million, compared to Adjusted EBITDA loss...

Continue reading

Augmedix Reports Strong Commercial Traction and Sales Momentum; Reports Fourth Quarter and Full Year 2022 Financial Results

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) — Augmedix (Nasdaq: AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022. “We finished 2022 with our best-ever fourth quarter in terms of bookings, with sales momentum continuing into 2023 with record first-quarter bookings, including our largest-ever clinician cohort signed,” said Manny Krakaris, Chief Executive Officer at Augmedix. “Our expanding portfolio of products has positioned us well for the large market opportunity in front of us, and we look forward to delivering strong results in 2023 with improving operating leverage.” Continued Krakaris, “Our innovative technology...

Continue reading

FitLife Brands Announces Fourth Quarter and Full Year 2022 Results

Omaha, March 27, 2023 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (OTC Pink: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the year ended December 31, 2022. Highlights for the year ended December 31, 2022 include:Total revenue was $28.8 million, an increase of 3.2% compared to $27.9 million in the prior year. Revenue for the fourth quarter was adversely affected by the timing of wholesale shipments, as explained further below. Online sales for the full year increased 23.2% to $8.2 million, representing 28% of total revenue compared to 24% in the prior year. For the fourth quarter, online sales increased 22.2% and accounted for 37% of total revenue compared to 23% during the same period in 2021. Gross profit declined...

Continue reading

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.21 per Share for Q1 2023

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.21 per share for the fiscal quarter ended February 28, 2023. This distribution, which is an increase of $0.01 per share over the prior distribution (a 5% increase), is payable to common stockholders on April 17, 2023 (as outlined in the table below).Ex-Date Record Date Payment Date Distribution Amount Return of Capital Estimate(1)4/6/23 4/10/23 4/17/23 $0.21 20%(1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information.Kayne Anderson Energy Infrastructure...

Continue reading

Kayne Anderson NextGen Energy & Infrastructure Announces Distribution of $0.16 per Share for Q1 2023

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) announced today a quarterly distribution of $0.16 per share for the fiscal quarter ended February 28, 2023. This distribution is payable to common stockholders on April 17, 2023 (as outlined in the table below).Ex-Date Record Date Payment Date Distribution Amount Return of CapitalEstimate(1)4/6/23 4/10/23 4/17/23 $0.16 80%(1) The return of capital estimate is based on the Funds anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information.Kayne Anderson NextGen Energy & Infrastructure, Inc. (NYSE: KMF) is a non-diversified, closed-end...

Continue reading

Parsons Awarded $16 Million US Army Intelligence Contract

CENTREVILLE, Va., March 27, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a $16 million firm-fixed-price contract by the U.S. Army for collection, processing, and dissemination of high-fidelity signature data. This contract has a five-year period of performance and is new work for the firm. “Parsons has delivered actionable solutions to the Department of Defense and federal agencies for more than 40 years,” said James Lackey, senior vice president for Parsons’ Mission Solutions sector. “As connectivity evolves, geopolitical conditions shift, and near-peer threats loom, our innovation and agility are bolstering readiness to help our nation confront rapidly evolving security challenges in the all-domain battlespace.” Parsons provides tailored intelligence solutions that accelerate...

Continue reading

Todos Medical Begins Trading on the OTC Pink Marketplace

New York, NY, Alpharetta, GA, Tel Aviv, ISRAEL, March 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Ordinary shares will begin trading on the OTC Pink marketplace beginning on March 27, 2023 as a result of the Company’s closing bid price falling below $0.001 for 5 consecutive trading days, from March 20, 2023 through March 24, 2023. For more information, please visit todosmedical.com. For more information on the Company’s 3CL protease inhibitor dietary supplement that provides immune support with 3CL protease inhibition. please visit www.mytollovid.com. About Todos Medical Ltd. Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic...

Continue reading

Broadwind Names Jeanette Press to Board of Directors

CICERO, Ill., March 27, 2023 (GLOBE NEWSWIRE) — Broadwind, Inc. (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced the appointment of Ms. Jeanette A. Press to its Board of Directors (the “Board”), effective March 22, 2023. With the appointment of Ms. Press, the Board returned its size to seven members, six of whom are independent. Ms. Press will serve as a member of the Board effective immediately, and the Board has determined to nominate Ms. Press for re-election as a director at the 2023 annual meeting of stockholders (the “2023 Annual Meeting”). She will also serve as a member of both the Audit and the Governance/Nominating committees of the Board. “Jeanette is a results-driven executive with proven expertise leading business...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.